Publication from 27.02.2024
Do new generations of active pharmaceuticals for human use require an adaption of the environmental risk assessment? - Part II: Case studies
… new generations of active pharmaceuticals for human use require an adaption of the environmental risk assessment? - Part II: Case studies In view of the advanced … pharmaceutical ingredients, the question arises as to whether the established standard procedures for the environmental risk assessment in the context of marketing …